Pelvic Floor Diagnostics Market
Pelvic Floor Diagnostics Market Analysis By Product (Anorectal Manometry Systems, Anorectal Manometry Catheters & Anorectal Expulsion Balloon Catheters) By Indication (Constipation, Faecal Incontinence, Rectocele & Enterocele) By End-user & Region – Insights 2022 to 2032
Analysis of Pelvic Floor Diagnostics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Pelvic Floor Diagnostics Market Outlook (2022-2032)
At the end of 2021, the global pelvic floor diagnostics market was valued at US$ 164.2 million. The market is anticipated to evolve at 5.4% CAGR and reach a value of US$ 289.9 million by the end of 2032.
As per a detailed industry analysis by Fact.MR, a market research and competitive intelligence provider, anorectal manometry systems dominated the global in 2021 in terms of revenue and market share, accounting for 50% market share.
Pelvic floor diagnostics contributed to around 1.5% share of the global gynecology devices market in 2021.
Pelvic Floor Diagnostics Market Size (2021)
US$ 164.2 Million
Estimated Market Value (2022)
US$ 171.2 Million
Forecasted Market Value (2032)
US$ 289.9 Billion
Global Market Growth Rate (2022-2032)
Share of Top 5 Countries
Key Market Players
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Pelvic Floor Diagnostics Demand Analysis (2012-2021) Vs. Market Outlook (2022-2032)
Over the last decade (2012-2021), the global pelvic floor diagnostics market expanded at a CAGR of 2.9% owing to the rising prevalence of human pelvic floor disorders well as diagnostic volumes for the same.
Some of the major factors driving the demand for pelvic floor diagnostics are the increasing prevalence of human pelvic floor disorders such as faecal incontinence, constipation, and pelvic organ prolapse, along with improvements in the technology of diagnostic devices in anorectal manometry systems.
Overweight and obesity are becoming a worldwide health problem associated with numerous comorbidities.
- As per WHO, around 2.8 million people die every year due to overweight and obesity problems.
Obesity is associated with a high prevalence of pelvic floor disorders. Patients with obesity are prone to a wide range of urinary, bowel, and sexual dysfunction problems. Faecal incontinence is quite common in patients who are suffering from obesity. Obesity causes added weight in the abdomen, which eventually puts pressure on the pelvic floor muscles. This pressure subsequently causes the weakening of muscles and incontinence, either faecal or urinary.
The most popular method for identifying irregularities in sphincter function and/or rectoanal synchronization is anorectal manometry systems. Manometry devices can record pressure data from a single anal canal point (known as conventional anal manometry) or can simultaneously record and show detailed data from the whole anal canal and distal rectum (high-resolution manometry). As a result, high-resolution manometry can detect pelvic floor anomalies that conventional anorectal manometry is unable to detect.
These factors have a positive influence on the pelvic floor diagnostic market, which is expected to expand at a CAGR of 5.4% during the forecasted period (2022-2032).
What Opportunity Lies Ahead for Key Providers of Pelvic Floor Diagnostics?
“Increasing Focus on Collaboration & Distribution Agreements for Pelvic Floor Devices”
Anorectal manometry systems are equipment employed in pelvic floor diagnosis. To acquire this equipment, the buyer must make large investments. Since these systems are expensive, not every hospital and diagnostics facility can afford them. As a result, market participants are concentrating on acquiring smaller or local players to broaden their customer base and use the technology of the acquired company to enhance the offerings of the acquiring company.
Additionally, key players are entering into exclusive partnerships with local distributors to distribute and market their products to reach a larger customer base. They provide technical training for the handling and utilization of their equipment.
- On 20th April 2022, Laborie acquired GI Supply, which specializes in specialty endoscopy and paracentesis products. The acquisition will help Laborie offer a broad range of gastroenterology products to healthcare practitioners, thus increasing its consumer base.
- In March 2016, Medspira partnered with Brighter Health Network to promote, market, and distribute the mcompass anorectal manometry system manufactured by Medspira.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What is Restraining Pelvic Floor Diagnostics Market Growth?
“High Costs Associated with Anorectal Manometry Systems”
Anorectal manometry systems are expensive devices. Very few hospitals and diagnostics facilities buy the devices due to the high cost of procurement and maintenance. The catheters utilized as well as the systems are expensive.
One of the main challenges limiting the growth of the pelvic floor diagnostics market is the higher expenses connected with the setup of anorectal manometry systems.
“Lack of Awareness for Pelvic Floor Disorders”
Pelvic floor disorder is a public health concern because it has negative psychosocial implications on a person's quality of life, including low self-esteem, anxiety, irritability, and depression. A majority of women do not seek medical care and continue to suffer in silence, despite the economic burden, psychosocial and physical morbidities, and incidence of faecal incontinence and pelvic organ prolapse.
There is a dearth of awareness of pelvic floor issues among expectant mothers. Obtaining antenatal specialized care and a tertiary degree will result in a higher level of knowledge competency. Hence, many government institutions have been working towards raising awareness about pelvic floor disorders and incontinence.
- The International Federation of Gynecology and Obstetrics (FIGO), a global NGO, ran a campaign on 4 March 2022 with the theme #BreakTheBias. This campaign highlighted the stigma among women for pelvic floor disorders and discussed the importance of education in destigmatizing these issues.
What is the U.S. Market Stance for Pelvic Floor Diagnostics?
“Increased Prevalence of Pelvic Floor Disorders in the Country”
The U.S. accounted for 92.5% of the North American pelvic floor diagnostics market in 2021 owing to the rising prevalence of faecal incontinence in the population.
Demand for pelvic floor diagnostics is rising along with the prevalence of human pelvic floor disorders, including fecal incontinence and pelvic organ prolapse.
- 10% to 20% of people in the United States experience defecation issues, which results in 1.2 million annual doctor visits, according to a W R. Grimes article.
A U.S. manufacturer named Laborie provides cutting-edge medical equipment and supplies for gynecology, urology, colorectal, and gastrointestinal procedures, as well as the diagnosis and treatment of pelvic health problems. It focuses on making investments in new technology, purchasing diverse companies, and utilizing their unique selling proposition.
Will Germany Be a Lucrative Market for Pelvic Floor Diagnostics?
“Rising Birth Rates Leading to Increasing Pelvic Organ Prolapse”
Germany accounted for 27.2% share of the European pelvic floor diagnostics market in 2021.
- According to a privately owned data technology company, Knoema, the number of births in Germany was 789.91 per thousand in 2020 when compared to 771.43 per thousand in the U.K.
Most women having multiple vaginal deliveries experience pelvic organ prolapse (POP). The descent of pelvic organs into the vagina because of weak ligaments or muscles is known as pelvic organ prolapse.
Therefore, with the increase in birth rates in Germany, the number of women prone to pelvic organ prolapse has also increased. This has indirectly increased the usage of anorectal manometers for diagnostics.
What are the Factors Fueling Demand for Pelvic Floor Diagnostics in China?
“Prevailing Incontinence Issues in Geriatric Population”
China accounted for 43.2% of the East Asia pelvic floor diagnostics market in 2021. Ageing of the population and gradually rising life expectancy will fuel demand for healthcare services, including pelvic floor diagnostics.
- Considering China's increased life expectancy, WHO projects that by 2040, 28% of the country's population would be over 60 years of age.
One of the main factors driving the growth in the China pelvic floor diagnostics market is the ageing population, which is considerably more prone to fecal incontinence.
- According to a recent NCBI article in 2020, the prevalence rate of fecal incontinence among the rural elderly Chinese population was nearly 12.3%.
Why is Demand for Anorectal Manometry Systems Gaining Traction?
“Higher Accuracy Offered by Anorectal Manometry Systems”
The anorectal manometry systems segment held nearly half of the global market share in 2021. This segment is expected to expand at 6.9% CAGR throughout the forecast period. High demand is mainly due to increasing diagnostics of human pelvic floor disorders.
Currently, high-resolution manometry systems are widely used. These systems are the latest approach for measuring anal pressures. In addition, they provide accurate reports for diagnostic purposes.
Which Indication is Driving High Growth of Pelvic Floor Diagnostics Market?
“Increase in Prevalence of Fecal Incontinence”
Faecal Incontinence held more than 43% revenue share in the global market in 2021.
The most typical pelvic floor condition for which people seek diagnosis is fecal incontinence. This is because the illness interferes with quality of life, which has an impact on daily activities. As a result, those who experience faecal incontinence seek diagnostics, accounting for the largest market share.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Manufacturers of pelvic floor diagnostic systems are compelled to work together and progress technology to grow their businesses. To access a larger consumer pool, market players are involved in distribution agreements, acquisitions, and mergers.
- In January 2022, Premier, Inc. granted Medspira a group purchasing agreement that went into effect on February 1, 2022.
- In April 2017, Diversatek Inc. combined two of its subsidiaries - Sandhill Scientific and Medovations - to form Diversatek Healthcare.
Similarly, recent developments related to companies operating in the pelvic floor diagnostics market have been tracked by the team at Fact.MR, which are available in the full report.
Key Segments in Pelvic Floor Diagnostics Industry Research
By Product :
- Anorectal Manometry Systems
- Standard Anorectal Manometry Systems
- High-Resolution Anorectal Manometry (HRAM) Systems
- Handheld Wireless Anorectal Manometry Systems
- Anorectal Manometry Catheters
- Air Charged Catheters
- Solid State Catheters
- Water Filled Catheters
- Single-Use Water Fused HARM Catheters
- Multiple-Use Water Fused HARM Catheters
- Anorectal Expulsion Balloon Catheters
- Single-Lumen Catheters
- Double-Lumen Catheter
- Anorectal Manometry Systems
By Indication :
- Faecal Incontinence
By End User :
- Diagnostic Imaging Centers
- Specialty Clinic
By Region :
- North America
- Latin America
- East Asia
- South Asia
- Middle East and Africa (MEA)
- FAQs -
The global pelvic floor diagnostics market reached a size of US$ 164.2 million at the end of 2021.
The global market for pelvic floor diagnostics is expected to reach US$ 289.9 million by 2032.
Revenue from pelvic floor diagnostics increased at a CAGR of 2.9% from 2012 to 2021.
The U.S., U.K., China, Germany, and Japan account for the most demand for pelvic floor diagnostic devices.
The U.S. accounted for 92.5% share of the North American market in 2021.
The Europe market is predicted to expand at 5.1% CAGR over the forecast period.
Top companies in this market are Medtronic Plc, Laborie, Inc., THD SpA, Medspira, Mui Scientific, and Diversatek, Inc.
Japan held a market share of 38.9% in the East Asian market in 2021.
The Indian market held a market share of 48.3% in the South Asian region in 2021.